This product is a broad-spectrum antifungal drug that has antibacterial effects on a variety of fungi, especially Candida albicans, and also has antibacterial effects on certain Gram-positive bacteria. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes.

This product is a broad-spectrum antifungal drug that has antibacterial effects on a variety of fungi, especially Candida albicans, and also has antibacterial effects on certain Gram-positive bacteria. Its mechanism of action is to inhibit the synthesis of fungal cell membranes and affect their metabolic processes.

Broad-spectrum penicillin antibiotics, when used in combination with clavulanic acid, can protect it from hydrolysis by β-lactamase, and have a good effect on enzyme-producing Staphylococcus aureus, Staphylococcus epidermidis and other bacteria.

It has a strong broad-spectrum β-lactamase inhibitory effect and has only weak antibacterial activity itself. Its antibacterial spectrum can be expanded when used in combination with amoxicillin.

This product is a semi-synthetic 14-membered macrolide antibiotic. Its antibacterial spectrum and antibacterial effect are basically similar to those of erythromycin. It is slightly less effective than erythromycin against Gram-positive bacteria, but stronger than erythromycin against Legionella pneumophila. Its antimicrobial effect against Chlamydia pneumoniae, Mycoplasma pneumoniae, and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the transfer of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.